Liao Patricia, DeSantis Anthony J, Schmeltz Lowell R, Schmidt Kathleen, O'Shea-Mahler Eileen, Victor Sara, Molitch Mark E
Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
J Diabetes Complications. 2008 Jul-Aug;22(4):229-34. doi: 10.1016/j.jdiacomp.2007.04.005. Epub 2008 Apr 16.
To assess insulin resistance postoperatively in patients with (DM) and without (nonDM) a prior diagnosis of diabetes.
Following cardiac surgery, 122 nonDM and 33 DM were treated with insulin infusions to obtain glucose levels <110 mg dl(-1). Glucose levels, insulin infusion rates, and insulin infusion rate/glucose ratios were calculated to assess insulin resistance.
The average blood glucose at insulin drip initiation (209 vs. 173 mg dl(-1); P<.001) and during the first 12 h (146 vs. 135 mg dl(-1); P<.05) was higher in DM, but during Hours 12-24 glucose levels were not different. The peak (5.7 vs. 4.1 U h(-1); P<.001) and average insulin drip rates (3.7 vs. 2.9 U h(-1); P<.01) were higher in DM. Insulin resistance (insulin drip rate/glucose ratio) was higher in DM during Hours 1-12 (0.029 vs. 0.022 U h(-1) mg(-1) dl(-1); P<.001), but not during Hours 12-24 (P=.57). To eliminate glucotoxicity as a cause of the insulin resistance, 23 DM patients were pair matched with 23 nonDM patients based first on glucose levels at drip initiation then by body mass index (BMI) and then catecholamine use to maintain blood pressure. The average blood glucose levels, insulin drip rates, and insulin resistance ratios were not significantly different between the pair-matched groups at all time points.
When matched for initial glucose levels, insulin resistance is not different between DM and nonDM following cardiac surgery, likely due to the overwhelming stress response. Insulin drip protocols used postoperatively do not have to be modified for those with a prior diagnosis of diabetes.
评估术前已诊断为糖尿病(DM)和未诊断为糖尿病(非DM)的患者术后的胰岛素抵抗情况。
心脏手术后,对122例非DM患者和33例DM患者进行胰岛素输注治疗,以使血糖水平<110mg/dl。计算血糖水平、胰岛素输注速率和胰岛素输注速率/血糖比值,以评估胰岛素抵抗。
DM患者在开始胰岛素滴注时(209 vs. 173mg/dl;P<.001)及最初12小时内(146 vs. 135mg/dl;P<.05)的平均血糖水平较高,但在12 - 24小时期间血糖水平无差异。DM患者的胰岛素滴注峰值(5.7 vs. 4.1U/h;P<.001)和平均胰岛素滴注速率(3.7 vs. 2.9U/h;P<.01)较高。在1 - 12小时期间,DM患者的胰岛素抵抗(胰岛素滴注速率/血糖比值)较高(0.029 vs. 0.022U/h·mg⁻¹·dl⁻¹;P<.001),但在12 - 24小时期间无差异(P = 0.57)。为消除葡萄糖毒性作为胰岛素抵抗的原因,根据开始滴注时的血糖水平,然后按体重指数(BMI)以及维持血压时使用的儿茶酚胺,将23例DM患者与23例非DM患者进行配对。在所有时间点,配对组之间平均血糖水平、胰岛素滴注速率和胰岛素抵抗比值均无显著差异。
在初始血糖水平匹配时,心脏手术后DM患者和非DM患者的胰岛素抵抗无差异,这可能是由于强烈的应激反应所致。对于术前已诊断为糖尿病的患者,术后使用的胰岛素滴注方案无需调整。